Table 2.
Correlation of SPARC Expression with Response to nab-Paclitaxel in 16 Head and Neck Cancer Patients.
| SPARC Status | Patients Responding | Patients Nonresponding |
| Positive (n = 12) | 10/12 (83%) | 2/12 (17%) |
| Negative (n = 4) | 1/4 (25%) | 3/4 (75%) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.